ARTICLE | Clinical News
Abraxane paclitaxel: Phase I/II started
March 3, 2008 8:00 AM UTC
NewYork-Presbyterian Hospital and Columbia University Medical Center began a Phase I/II trial to evaluate the safety of Abraxane in 18 patients for 6 weeks. The second portion of the study will enroll...